Patents by Inventor Francois-Xavier Orveillon

Francois-Xavier Orveillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention and treatment of sub-clinical PCVD
    Patent number: 9132187
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: September 15, 2015
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Axel Lischewski
  • TREATMENT OF PIGS WITH PCV2 ANTIGEN
    Publication number: 20140377298
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: September 10, 2014
    Publication date: December 25, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky FACHINGER, Knut ELBERS, Axel LISCHEWSKI, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Michael D. PIONTKOWSKI
  • Treatment of pigs with PCV2 antigent
    Patent number: 8865183
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: December 14, 2007
    Date of Patent: October 21, 2014
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael Piontkowski
  • NOVEL EUROPEAN PRRSV STRAIN
    Publication number: 20140255442
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Application
    Filed: May 19, 2014
    Publication date: September 11, 2014
    Applicant: BOEHRINGER INGELHEIM VETMEDICA GMBH
    Inventors: Kim BURGARD, Jeremy KROLL, Sarah M. LAYTON, Volker OHLINGER, Francois-Xavier ORVEILLON, Stefan PESCH, Michael Dennis PIONTKOWSKI, Michael B. ROOF, Philip UTLEY, Eric Martin VAUGHN
  • European PRRSV strain
    Patent number: 8765142
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Grant
    Filed: February 14, 2012
    Date of Patent: July 1, 2014
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Kim Burgard, Jeremy Kroll, Sarah M. Layton, Volker Ohlinger, Francois-Xavier Orveillon, Stefan Pesch, Michael Dennis Piontkowski, Michael B. Roof, Philip Utley, Eric Martin Vaughn
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20130273099
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: June 24, 2013
    Publication date: October 17, 2013
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 8496940
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: April 4, 2011
    Date of Patent: July 30, 2013
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • PROPHYLAXIS AND TREATMENT OF PRDC
    Publication number: 20130115236
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: December 28, 2012
    Publication date: May 9, 2013
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • NOVEL EUROPEAN PRRSV STRAIN
    Publication number: 20120213810
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Application
    Filed: February 14, 2012
    Publication date: August 23, 2012
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, GMBH
    Inventors: Kim BURGARD, Jeremy KROLL, Sarah M. LAYTON, Volker OHLINGER, Francois-Xavier ORVEILLON, Stefan PESCH, Michael Dennis PIONTKOWSKI, Michael B. ROOF, Philip UTLEY, Eric Martin VAUGHN
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20110182935
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: April 4, 2011
    Publication date: July 28, 2011
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • TREATMENT OF PRDC IN PIGS
    Publication number: 20110129495
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: February 9, 2011
    Publication date: June 2, 2011
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 7943298
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: May 17, 2011
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Von Richthofen, Axel Lischewski
  • TREATMENT OF PIGS WITH PCV2 ANTIGENT
    Publication number: 20110091499
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: December 14, 2007
    Publication date: April 21, 2011
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael Piontkowski
  • Treatment of PRDC in pigs
    Patent number: 7914992
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Grant
    Filed: January 3, 2008
    Date of Patent: March 29, 2011
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20090010954
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: February 13, 2008
    Publication date: January 8, 2009
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Von Richthofen, Axel Lischewski
  • TREATMENT OF PRDC IN PIGS
    Publication number: 20080305128
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: January 3, 2008
    Publication date: December 11, 2008
    Applicant: BOEHRINGER INGELHEIM VETMEDICA, INC.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle von Richthofen, Axel Lischewski